Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPEX/4127 stock hub

TPEX/4127 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TPEX/4127is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.8B
Taipei Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TPEX/4127
In the news

Latest news · TPEX/4127

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12P50 15.5P75 22.5
Trailing P/En/a
P25 14.4P50 18P75 31.9
ROE-2.2
P25 -16.2P50 0.3P75 9.8
ROIC-1.8
P25 -11.7P50 -0.2P75 8.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TPEX/4127 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
199
Groups with data
11
Currency
TWD
Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Taiwan
Country code
TW
Employees
88
Employees Change
28%
Employees Change Percent
46.67
Enterprise value
TWD 2.3B
Exchange
Taipei Exchange
Financial currency
TWD
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
TW0004127006
Last refreshed
2026-05-10
Market cap
TWD 1.8B
Price
TWD 39.8
Price currency
TWD
Rev Per Employee
5,815,829.55x
Sector
Healthcare
Sic
2834
Symbol
tpex/4127
Website
https://www.tlb.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

9
MetricValue
Earnings Yield
-0.56%
EV Earnings
-221.14x
EV/FCF
-572.03x
EV/Sales
4.43x
FCF yield
-0.22%
P/B ratio
3.84x
P/S ratio
3.56x
PE Ratio3 Y
78.52x
PE Ratio5 Y
55.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
-3.15%
EBITDA Margin
-1.28%
Gross margin
56.26%
Gross Profit
TWD 287.9M
Gross Profit Growth
25.24%
Gross Profit Growth Q
51.23%
Gross Profit Growth3 Y
-5.07%
Gross Profit Growth5 Y
2.71%
Net Income
TWD -10.3M
Net Income Growth Years
0%
Pretax Margin
-2.3%
Profit Margin
-2%
Profit Per Employee
TWD -116,489
ROA
-0.97
Roa5y
2.1
ROCE
-3.4
ROE
-2.15
Roe5y
5.85
ROIC
-1.77
Roic5y
4.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

19
MetricValue
Cagr10y
7.29%
Cagr15y
2.76%
Cagr1y
9.5%
Cagr20y
4.18%
Cagr3y
37.28%
Cagr5y
31.67%
Div CAGR10
5.24%
Div CAGR3
0%
Div CAGR5
0%
EPS Growth Years
0
OCF Growth
-60.48%
OCF Growth10 Y
-16.29%
OCF Growth3 Y
-4.21%
Revenue Growth
32.86x
Revenue Growth Q
51.53x
Revenue Growth Quarters
3x
Revenue Growth Years
1x
Revenue Growth3 Y
-1.07x
Revenue Growth5 Y
3.49x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
TWD 0.49
Assets
TWD 1.2B
Cash
TWD 152.3M
Current Assets
TWD 285.1M
Current Liabilities
TWD 708.9M
Debt
TWD 598M
Debt Equity
TWD 1.26
Debt FCF
TWD -151
Equity
TWD 474M
Interest Coverage
-1.45
Liabilities
TWD 709.2M
Long Term Assets
TWD 898.1M
Long Term Liabilities
TWD 304,000
Net Cash
TWD -445.7M
Net Cash By Market Cap
TWD -24.47
Net Debt Equity
TWD 0.94
Tangible Book Value
TWD 473.6M
Tangible Book Value Per Share
TWD 10.35
WACC
5.52

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.4
Inventory Turnover
3.57
Net Working Capital
TWD 21.9M
Quick ratio
0.28
Working Capital
TWD -423.8M
Working Capital Turnover
TWD -1.75

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
0.01%
Dividend per share
TWD 0
Last Dividend
TWD 0.5

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
102.02%
1Y total return
9.49%
200-day SMA
34.45
3Y total return
158.76%
50-day SMA
36.67
50-day SMA vs 200-day SMA
50over200
5Y total return
295.75%
All Time High
47.8
All Time High Change
-16.74%
All Time High Date
2024-05-24
All Time Low
7.16
All Time Low Change
455.87%
All Time Low Date
2008-10-28
ATR
1.18
Beta
0.47
Beta1y
0.34
Beta2y
0.18
Ch YTD
28.39
High
40.5
High52
42.2
High52 Date
2026-02-02
High52ch
-5.69%
Low
39.3
Low52
29
Low52 Date
2025-12-30
Low52ch
37.24%
Ma50ch
8.54%
Price vs 200-day SMA
15.52%
RSI
64.71
RSI Monthly
60.07
RSI Weekly
63.65
Sharpe ratio
0.33x
Sortino ratio
0.77
Total Return
0.01%
Tr YTD
28.39
Tr15y
50.5%
Tr1m
11.33%
Tr1w
3.24%
Tr3m
1.92%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
TWD -16.1M
Operating margin
-3.15

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
19,231,100%
Net Borrowing
262,623,000
Shares Insiders
0.08%
Shares Out
45,760,000
Shares Qo Q
0%
Shares Yo Y
-0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

56
MetricValue
Adjusted FCF
TWD -4M
Average Volume
119,039.45x
Bv Per Share
10.36
CAPEX
TWD -23.2M
Ch10y
96.06
Ch15y
36.07
Ch1m
11.33
Ch1w
3.24
Ch1y
9.49
Ch20y
96.25
Ch3m
1.92
Ch3y
155.1
Ch5y
290.2
Ch6m
24.77
Change
1.14%
Change From Open
-1.73
Close
39.35
Days Gap
2.92
Depreciation Amortization
9,566,000
Dollar Volume
12,065,608.8
Earnings Date
2026-03-20
EBIT
TWD -16.1M
EBITDA
TWD -6.6M
EPS
TWD -0.22
F Score
2
FCF
TWD -4M
FCF EV Yield
-0.17x
FCF Per Share
TWD -0.09
Financing CF
254,121,000
Fiscal Year End
December
Founded
1,971
Income Tax
TWD -1.5M
Investing CF
-281,708,000
Is Primary Listing
1
Last Earnings Date
2025-11-11
Last Report Date
2025-12-31
Last Split Date
2008-09-24
Last Split Type
Forward
Ma150
34.19
Ma150ch
16.41%
Ma20
37.9
Ma20ch
5.01%
Net CF
-8,356,000
Open
40.5
P OCF Ratio
94.7
Position In Range
41.67
Ppne
335,552,000
Price Date
2026-05-08
Ptbv Ratio
3.85
Relative Volume
2.89x
Revenue
511,793,000x
Tax By Revenue
-0.29x
Tr20y
126.59%
Tr6m
24.77%
Volume
303,156
Z Score
1.37
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TPEX/4127 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/4127 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+9.5%
S&P 500 1Y: n/a
3Y total return
+158.8%
S&P 500 3Y: n/a
5Y total return
+295.8%
S&P 500 5Y: n/a
10Y total return
+102.0%
S&P 500 10Y: n/a
Ownership

Who owns TPEX/4127?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+0.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.0%
Negative means the company is buying back shares.
Technical

TPEX/4127 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
64.7
Neutral momentum band
Price vs 200-day MA
+15.5%
50/200-day relationship not available
Beta (5Y)
0.47
Less volatile than the market
Sharpe ratio
0.33
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TPEX/4127

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4127 stock rating?

tpex/4127 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4127 analysis?

The full report lives at /stocks/tpex/4127/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4127?

The latest report frames tpex/4127 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4127 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.